ABINGDON, England, July 19, 2012 /PRNewswire/ --
Primcogent Solutions - supplier of the revolutionary ZERONA non-invasive body contouring technology in North America and Western Europe - has announced the launch of Lunula Laser, a clinically proven, low level laser therapy for onychomycosis, for distribution exclusively in Europe. Lunula Laser brings new hope to people suffering from fungal nail infections, providing a completely safe, pain-free treatment of onychomycosis in just two 12-minute treatments.
(Logo: http://photos.prnewswire.com/prnh/20120719/546037-a )
(Photo: http://photos.prnewswire.com/prnh/20120719/546037-b )
Manufactured by Erchonia, Lunula Laser is based on Low Level Laser Technology (LLLT) and provides effective treatment of onychomycosis without the risks and harmful side effects of oral medication, or the pain and recovery time associated with other laser treatments. It combines two different wavelength lasers - one at 405 nm for direct fungicidal activity and one at 635 nm to stimulate a natural immune response - to provide effective clearing of the nail bed within three months. In a recent study of 105 toenails, clinicians observed a mean percentage change in clear nail bed of 30.4 percent, or 5 mm. Furthermore, 62 percent of toenails treated achieved at least a 25 percent increase in clear nail after 3 months, thus validating the use of Lunula Laser to target onychomycosis.
The Lunula Laser has been specifically designed for use by physicians and their staff, requiring very little set-up time and no operator intervention, creating a complete walk-away treatment thanks to preset dosage times and output energies. This innovative therapy provides effective relief for patients after just two treatments, alleviating the pain and embarrassment of unsightly nail fungus by restoring growth of clear, healthy nails.
To learn more about the Lunula Laser, register for one of Primcogent Solutions' free webinars at http://www.lunulasuccess.com
For more information, visit http://www.primcogent.com.
About Primcogent Solutions
Primcogent Solutions is dedicated to offering healthcare products to the medical community backed by a clear, logical and convincing scientific and clinical foundation. Primcogent Solutions' signature product, ZERONA, manufactured by Erchonia Medical, is the only platform that is CE-marked and FDA cleared for the safe and effective simultaneous reduction of fat from the hips, waist and thighs. Primcogent Solutions' revolutionary non-invasive body contouring technology, along with its unique physician business model, enhances practice profitability by eliminating the risks associated with purchasing capital equipment. For more information, visit http://www.primcogent.com.
About Erchonia
Erchonia is the global leader in low-level laser healthcare applications. Over the last 15 years Erchonia has been conducting research and development with the world's leading physicians to advance the science of low-level lasers. Prior to market introduction, all Erchonia lasers are proven safe and effective through independent clinical trials. Currently, thousands of Erchonia's lasers are used daily to reduce body fat, eliminate pain, accelerate healing, and treat acne. For additional information, visit http://www.erchonia.com.
For more information, contact Primcogent Solutions,
20 Milton Park
Abingdon
Oxon
OX14 4SH
Tel: +44(0)1235-841590
Email: sales@primcogent.com
http://www.primcogent.com
© 2012 kdm communications limited
Editorial contact for further information or follow-up
Sarah Allen at kdm communications limited
Sarah Allen, Director
kdm communications limited
Cressner House, Suite 3,
12 Huntingdon Street, St Neots, PE19 1BG
Tel +44(0)1480-405333 | Fax +44(0)1480-477833
SOURCE Primcogent Solutions